Lilly Boosts R&D with $700M Boston Center
Lilly's new Boston facility enhances RNA/DNA research, hosting 500 scientists and expanding Gateway Labs to the East Coast.
- Latest
- Trending
Lilly's new Boston facility enhances RNA/DNA research, hosting 500 scientists and expanding Gateway Labs to the East Coast.
PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
Discover how Novo Nordisk, Moderna, and Regeneron are poised for growth amidst market volatility with innovative biotech solutions.
Amgen plans a new site in Hyderabad to boost digital capabilities and advance its medicine pipeline.
Amgen taps into India's talent with new Hyderabad innovation site for advancing biotechnology and AI.
10x Genomics sees 4% revenue growth in Q2 2024 but lowers full-year outlook due to economic headwinds affecting instrument sales.
DCTY's acquisition marks a milestone in China's biotech scene, introducing advanced TCR and CAR T-cell therapies domestically.
Southern Miss advances biomaterials research for immune disease treatment with a $2.5M collaboration, boosting Mississippi's biotech.
Stocks surged at the opening but saw steep declines by closing. Learn why tech, Disney, and bond yields impacted the ...
AbCellera Biologics Inc. progresses with their TCE platform and strategic partnerships, aiming for CTA submissions in Q2 2025.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.